Ki-67 and cytokeratin 16 expression in several lesion types of hidradenitis suppurativa compared to keratosis pilaris and psoriasis inversa. A pilot investigation - Pilot: Ki-67 and CK16 in HS, keratosis pilaris and psoriasis inversa

niversitair Medisch Centrum Groningen0 个研究点目标入组 50 人开始时间: 待定最近更新: 2024年4月15日

适应症

试验速览

暂无简介。

•Healthy controls:
•In order to be eligible to participate in this study, a subject must meet all of the following
•- Subjects are not affected with HS, psoriasis inversa and keratosis pilaris.
•- Subjects do not have another skin disease located at the armpits or groins
•- Age 18-65 years
•Patients with psoriasis inversa and keratosis pilaris:
•In order to be eligible to participate in this study, a subject must meet all of the following
•- Subjects are not affected with HS
•- Subjects do not have another skin disease located at the site of the affected skin.
•- Age 18-65 years;Patients with HS that have pseudo-comedone lesions
•In order to be eligible to participate in this study, a subject must meet all of the following
•- Subjects are not affected with psoriasis inversa. Also, subjects are not affected with keratosis pilaris at the site of pseudo-comedones.
•- Subjects do not have another skin disease located at the site of the affected skin.
•- Age 18-65 years;Patients with HS with inflammatory nodules via left-over material from STEEP-surgery
•- Subjects are not affected with psoriasis inversa. Also, subjects are not affected with keratosis pilaris at the surgical site.
•- subjects do not have other skin manifestations at the site of STEEP-surgery, particularly no psoriasis inversa and keratosis pilaris.
•- Age 18-65 years

•A potential subject who meets any of the following criteria will be excluded from participation
•in this study:
•- Subjects who have not given informed consent
•- Subjects <18 and >65 years old

发起方